Uso de espironolactona o doxazosina en pacientes con hipertensión arterial refractaria

In patients with resistant hypertension, the addition of either spironolactone or doxazosin resulted in a significant decrease in BP, though the decrease appeared to be greater with spironolactone. The presence of diabetes complicated BP control.